Sheheryar Kabraji, BMBCh, is a breast medical oncologist and Associate Professor of Oncology at Roswell Park Comprehensive Cancer Center, where he serves as Chief of Breast Medicine and Director of Breast Translational Research. He is also a faculty member in the Department of Molecular and Cellular Biology. His clinical practice focuses on breast medical oncology, management of advanced and recurrent disease, and personalized systemic therapy. Dr. Kabraji’s research centers on tumor dormancy and therapeutic resistance, tumor-immune interactions, and biomarker-driven translational therapeutics. He leads the Kabraji Lab with a bench-to-bedside approach aimed at translating scientific discovery into improved patient care. His work has been recognized with the Susan G. Komen Career Catalyst Research Grant and the BCRF-AACR Career Development Award. He earned his medical degree from Oxford University Medical School, completed his internal medicine residency at Massachusetts General Hospital, and went on to fellowship training in hematology and medical oncology at Dana-Farber Cancer Institute/Mass General Brigham.
Associate Professor
Medical School
2006 – 2009
Residency
2010 – 2013
Fellowship
2013 – 2017